Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $652K 7,171 sh | Sep 11, 2026 |
| 17 | Kerr Michael SGeneral Counsel |  QTWOQ2 Holdings, Inc.Open-market sale | SELL | $39K 636 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 1,160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $196K 920 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 360 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $93K 440 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 1,169 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Taich AdamChief Financial Officer |  TXG10x Genomics, Inc.Open-market sale · 10b5-1 plan | SELL | $898K 13.8K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Briggs TeresaDirector |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $35K 548 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 15 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $525K 468.7K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 15 | Tak Paul PeterDirector, Chief Executive Officer |  CADLCandel Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $621K 59.4K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 14 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $179K 10.2K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Taich AdamChief Financial Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 1,206 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 120 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 80 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 1,100 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,630 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 10 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.97M 20.5K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer | OCGNOcugen, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $344K 640 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $277K 522 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $345K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 512 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 520 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $558K 1,040 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Gracey CraigChief Accounting Officer |  OMDAOmada Health, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $87K 160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $652K 1,202 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $184K 347 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $837K 1,539 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $116K 215 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $212K 396 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 362 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $196K 368 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $371K 687 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $415K 761 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $69K 131 sh | Sep 11, 2026 traded Sep 9, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K